despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.
of the life claims declined, 0.85 per cent were due to mis-representation and 0.16 per cent due to the definition of terminal illness not being met.
.
. (image: rex/shutterstock)
.
.
.
.
it shows that the longest waits for cancer treatment have soared since 2010.
.
"i can't think of anything else where we have done that medically," van den veyver said.
.